Abstract
Background/Aims
Bone marrow mesenchymal stromal cells (BM-MSCs) exert diverse functions, including supporting alcohol detoxification and providing a niche for monocyte development. However, their role in regulating monocytes during alcohol-associated liver disease (ALD) remains unclear. This study investigates how BM-MSCs orchestrate the egress of anti-inflammatory monocytes from BM to the liver in ALD.
Methods
Wild-type, leptin receptor (LepR)⁺ BM-MSC-specific Slc7a11 knockout, and natural killer (NK) cell-specific Grm5 knockout mice were fed an ethanol diet for 8 weeks. Tissue analyses were performed using single-cell RNA sequencing (scRNA-seq), immunostaining, and flow cytometry. Blood and liver samples from ALD patients were examined.
Results
scRNA-seq revealed a distinct population of BM-derived Ly6Clow hepatic macrophages expressing interleukin-1 receptor 2 (IL-1R2), an IL-1β decoy receptor, in ethanol-fed mice. In the BM, alcohol exposure upregulated the gene expression of alcohol-metabolizing enzymes (Adh1, Aldh2), xCT (Slc7a11), and chemokines (Cxcl9, Cxcl10) in LepR+ BM-MSCs, promoting NK cell recruitment and interferon-γ (IFN-γ) production via metabotropic glutamate receptor 5 (mGluR5) activation. Subsequently, IFN-γ enhanced IL-1R2 expression and suppressed CX3CR1 in neighboring Ly6Clow BM monocytes, facilitating their hepatic migration. LepR+ BM-MSC-specific xCT and NK cell-specific mGluR5 knockout mice exhibited exacerbated liver injury and elevated blood IL-1β levels, while recombinant IL-1R2 administration ameliorated ALD in wild-type mice. Consistently, increased IL-1R2 levels were observed in plasma, CD14+CD16+ blood monocytes, and liver tissues of ALD patients.
Conclusions
We identified a BM-liver axis in which glutamate released by BM-MSCs activates mGluR5 in BM NK cells, driving IL-1R2+ monocyte migration to the liver and attenuating ALD progression.
Keywords: Alcohol-associated steatohepatitis, Interferon-gamma, Interleukin-1 beta, Natural killer cell, xCT protein
Graphical Abstract

INTRODUCTION
Chronic alcohol consumption causes alcohol-associated liver disease (ALD), including steatosis, inflammation, fibrosis, and hepatocellular carcinoma [1]. It also elevates interleukin-1β (IL-1β), which drives ALD progression and frequently results in liver failure, underscoring the crucial role of IL-1β [2]. Given that most individuals who consume high amounts of alcohol develop alcohol-associated steatosis but rarely progress to alcohol-associated inflammation [1], it is plausible that unidentified defense mechanisms exist against IL-1β that help to maintain liver function. Unlike IL-1 receptor 1 (IL-1R1), which contains an intracellular toll-IL-1 receptor domain and mediates inflammatory signaling, IL-1R2 is a decoy receptor lacking this domain and competing with IL-1R1 to dampen IL-1β signaling [3]. IL-1R2 exists in membrane-bound or soluble forms and is predominantly expressed by bone marrow (BM)-derived monocytes or neutrophils [3]. Although F4/80+CD11b+ monocytes comprise a heterogeneous population that includes pro-inflammatory (Ly6Chigh) and anti-inflammatory (Ly6Clow) subsets [4,5], their potential hepatoprotective role and IL-1R2 expression in the context of ALD remain unexplored.
Recent studies have highlighted the importance of extrahepatic alcohol metabolism across multiple organs [6]. Given that BM mesenchymal stromal cells (BM-MSCs) exhibit hepatocyte-like properties [7,8], they may also metabolize alcohol and thereby influence the BM microenvironment. Among the various subsets, leptin receptor (LepR)-expressing BM-MSCs, characterized by platelet-derived growth factor receptor-α (PDGFRα)+, Sca-1+/‒, CD45‒, and Ter119‒, reside in the perisinusoidal region and maintain the Ly6Chigh and Ly6Clow monocyte pool [9,10]. These cells also recruit C-X-C motif chemokine receptor 3 (CXCR3)-expressing lymphocytes through the expression of C-X-C motif chemokine ligand 9 (CXCL9) and CXCL10 [11]. Collectively, these findings suggest that LepR+ BM-MSCs could be the first to encounter circulating alcohol and, in turn, influence the characteristics of BM monocytes and lymphocytes in diverse ways. To date, however, this possibility has not been investigated. Given that BM-MSCs generate reactive oxygen species (ROS) during alcohol metabolism through alcohol dehydrogenase 1 (ADH1), cytochrome P450 2E1 (CYP2E1), and aldehyde dehydrogenase 2 (ALDH2) [1], they would rely on intrinsic antioxidant systems to preserve cellular homeostasis. Indeed, MSCs exert antioxidant effects, including activation of the glutathione system, which contributes to their cytoprotective and anti-inflammatory properties in various disease models [12]. During this process, to scavenge ROS, xCT mediates cystine uptake for glutathione (GSH) synthesis in exchange for glutamate export; the released glutamate can act as a neurotransmitter by activating glutamate receptors [13]. However, the presence of xCT and the role of secreted glutamate in BM-MSCs have not yet been investigated in ALD.
Recent reports have emphasized that metabotropic glutamate receptor 5 (mGluR5), group I mGluR, is expressed in natural killer (NK) cells and regulates their cytokine production such as interferon-γ (IFN-γ) in adipose tissue and liver [14,15]. In particular, during infection, IL-12-mediated IFN-γ production in BM NK cells primes the regulatory function of monocytes before their egress from the BM and direct injection of recombinant IFN-γ decreased fractalkine receptor (CX3CR1) in blood monocytes [16]. Additionally, C-C chemokine receptor type 2 (CCR2) in monocytes is the main receptor for their release from the BM, whereas CX3CR1 decreases their motility and reduces adherence to endothelial cells in the BM, thereby limiting their release into the bloodstream [17]. Consistently, MSCs express and secrete CX3CL1, which in turn suppresses microglial activation induced by pro-inflammatory stimuli [18]. These findings suggest that IFN-γ-mediated downregulation of CX3CR1 in BM monocytes may facilitate their migration into the inflamed liver. Once recruited from the BM, Ly6C+ monocytes/macrophages in the liver play pivotal roles in either resolving inflammation or promoting tissue repair, depending on their phenotypic state, whereas Kupffer cells, the tissue-resident macrophages, maintain homeostasis and serve as sentinels against hepatic injury [19].
Therefore, we investigated whether alcohol-metabolizing BM-MSCs regulate the egress of IL-1R2+ monocytes into the circulation through glutamate-mediated mGluR5 activation in NK cells and down-regulation of CX3CR1 in BM monocytes, thereby preventing ALD. Our results suggest that the BM-liver axis mediated by IL-1R2+ monocytes is an adaptive mechanism that limits excessive alcohol-induced inflammation.
MATERIALS AND METHODS
Mice
All mice were maintained on a 12 hours light-dark cycle in a specific pathogen-free animal facility at the Korea Advanced Institute of Science and Technology (KAIST, Korea), and all experimental protocols were approved by the Institutional Animal Care and Use Committee of KAIST (approved no. KA2021-71). C57BL/6J wild type (WT), IFN-γ reporter with endogenous polyA transcript (GREAT), Leprcre, CX3CR1GFP, Grm5f/f, β-actin-enhanced green fluorescent protein (eGFP), and tdTomato mice were purchased from Jackson Laboratory. The Slc7a11 tm1a and Nkp46-iCre mice were acquired from the European Mutant Mouse Archive. Slc7a11f/f mice were generated by crossing with Flippase mice. For animal experiments, male mice aged 8–10 weeks were fed a Lieber-DeCarli liquid diet containing 4.5% ethanol (EtOH) or an isocaloric maltose-dextrin (Pair)-fed control diet for 8 weeks. Littermates were used as controls, and all animal experiments were repeated three times. For IL-1R2 experiments, mice were fed a 5% EtOH diet for 10 days, followed by oral gavage with 40% EtOH (4 g/kg) and sacrificed 6 hours later. On day 7, mice were randomly allocated to either the vehicle (saline) or recombinant mouse IL-1R2 (R&D Systems, 0.1 mg/kg) group, and the respective solutions were administered intraperitoneally every 24 hours until the binge drinking.
Human subjects
Peripheral blood samples and liver tissues of healthy controls and patients with alcohol-associated steatotic liver (ASL), steatohepatitis (ASH) and liver cirrhosis (ALC) were provided from the Korea University College of Medicine and the Seoul Metropolitan Government Seoul National University Boramae Medical Center. Informed consent was obtained from each individual. Overall procedures were approved by the Institutional Review Board of Korea University College of Medicine (No. 2019GR0452) or Seoul Metropolitan Government Seoul National University Boramae Medical Center (No. 16-2013-45). Patients who consumed a high amount of alcohol (>30 g day-1 for men and 20 g day-1 for women) were enrolled, and the stages of the disease were evaluated based on the liver histology or clinical parameters. Patients who had viral infections or autoimmunerelated liver diseases were excluded. For general characteristics of patients, please see Supplementary Table 1.
Statistical analysis
Statistical analyses were performed with Prism version 8.0 (GraphPad Software, San Diego, CA, USA), and data are shown as the mean±standard error of the mean. Linear regression with r square and P-values was conducted for correlative analysis. For the evaluation of statistical significance between the two groups, the unpaired Student t-test was used, and a One-way ANOVA with Tukey’s or Dunnett’s test for multiple comparisons was used for more than two groups. An adjusted P-value was used for next-generation sequencing analysis. Otherwise, a P-value <0.05 was thought to be statistically significant. Other materials and methods are described in the Supporting Information, including the list of antibodies (Supplementary Table 2) and primer sequences for qPCR (Supplementary Table 3).
RESULTS
Chronic ethanol intake increases BM-derived IL-1R2+Ly6Clow macrophages in the liver
To explore anti-inflammatory macrophages under chronic alcohol exposure, isolated hepatic F4/80+CD11b+ macrophages from Pair- and EtOH-fed WT mice were utilized for single-cell RNA sequencing (scRNA-seq) analysis (Supplementary Fig. 1A). After clustering hepatic macrophages of Pair or EtOH-fed mice (Fig. 1A; Supplementary Fig. 1B), we performed sub-clustering analysis and obtained two Ly6Chigh (Ly6Chigh_1 and Ly6Chigh_2) and three Ly6Clow (Ly6Clow_1, Ly6Clow_2, and Ly6Clow_3) clusters (Fig. 1B). Interestingly, in addition to the marked increase in proinflammatory Ly6Chigh cluster following chronic alcohol consumption, the proportions of the Ly6Clow_2 (94.3%) and Ly6Clow_3 (77.8%) clusters, which arise from anti-inflammatory Ly6Clow_1 (10.9%), were also notably elevated in EtOH-fed mice (Fig. 1B).
Figure 1.

Chronic ethanol consumption increases IL-1R2+Ly6Clow macrophages in the liver. (A) The feature plot shows macrophage cluster by condition (upper), and macrophage marker genes (bottom). (B) The feature plot illustrates the clustering of macrophage subsets and relative frequencies of each subset in the livers of Pair- or EtOH-fed mice. Trajectory analysis of Ly6Clow macrophages. Heatmap displays marker genes associated with each cluster. (C) Enriched canonical pathways and heatmap of significantly upregulated genes in EtOH-fed Ly6Clow macrophages compared with Pair-fed controls. (D) Quantification of serum IL-1β levels in Pair- or EtOH-fed mice (right). Feature plot and violin plot showing Il1r2 expression levels in Ly6Clow macrophages (left). (E) Representative immunostaining of liver tissues for F4/80 (red), IL-1R2 (green), and nuclei (blue). Yellow triangles mark IL-1R2+F4/80+ cells. Scale bars, 50 μm. (F) Flow cytometry analysis of IL-1R2 expression levels in F4/80+CD11b+ hepatic macrophages (left) or blood monocytes (right) (n=5/group). Data are presented as mean±standard error of the mean. IL-1R, interleukin-1 receptor; MFI, mean fluorescence intensity; UMAP, uniform manifold approximation and projection. *P<0.05, **P<0.01.
Subsequently, canonical pathway analysis revealed a significant enrichment of genes associated with the regulation of IL-1β production in Ly6Clow macrophages from EtOH-fed mice compared with controls, along with enrichment of cellular stress-related pathways (Fig. 1C). In particular, Il1r2, which encodes the decoy receptor for IL-1β, was significantly localized and upregulated in the Ly6Clow_2 cluster of EtOH-treated Ly6Clow macrophages, consistent with a marked increase in serum IL-1β by chronic alcohol intake (fold change >1.5, P<0.0001) (Fig. 1D). Consistently, the expression levels of genes that mediate the IL-1β signaling pathway (Myd88, Irak4, Traf6, Ikbkb, and Map3k7) were lower in Ly6Clow_2 than in Ly6Chigh clusters (Supplementary Fig. 1C). Moreover, IL-1R2+F4/80+ cells were undetectable in Pair-fed mice, whereas considerable numbers of these cells were observed in the steatotic livers of EtOH-fed mice (Fig. 1E; Supplementary Fig. 1D, 1E). Furthermore, surface levels of IL-1R2 were elevated not only in hepatic F4/80+CD11b+Ly6Clow macrophages but also in blood F4/80+CD11b+Ly6Clow monocytes of EtOH-fed mice compared with those of the controls (Fig. 1F). These results suggest that the increased hepatic infiltration of BM-derived IL-1R2+Ly6Clow macrophages in EtOH-fed mice may represent an adaptive, protective response that attenuates IL-1β-mediated inflammation.
Alcohol metabolism in LepR+ MSCs leads to xCT-mediated glutamate excretion
To elucidate the mechanisms underlying the increased hepatic infiltration of IL-1R2+Ly6Clow monocytes, we examined the effects of EtOH on BM niche cells that regulate the maturation and education of monocytes before their release into the circulation [10,16]. In scRNA-seq of BM niche cells in WT mice [20], we found that Lepr+ MSCs expressed not only Pdgfra but also genes encoding alcohol-metabolizing enzymes, including Adh1 and Aldh2, while lacking Cyp2e1 (Fig. 2A; Supplementary Fig. 2A, 2B). Additionally, the expression levels of Adh1 and Aldh2 were significantly higher in isolated LepR+ MSCs than in whole BM cells (Fig. 2A). To further validate these findings, WT or Lepr reporter (Lepr-Cre x tdTomato) mice were fed EtOH-diet for 8 weeks. Immunostaining revealed that ADH1 expression was specifically elevated in LepR+ MSCs within the perivascular regions, accompanied by ALDH2 expression (Fig. 2B).
Figure 2.

LepR+ BM-MSCs secrete glutamate via xCT following alcohol exposure. (A) The feature plots for scRNA-seq of BM niche in WT mice (GSE108892) (left), and qRT-PCR analysis of whole BM cells or sorted LepR+ MSCs from WT mice (n=3/group; right). (B) Representative immunostaining of ADH1 (top) and ALDH2 (bottom) in BM tissues from tdTomato x Lepr-cre mice after 8 weeks of Pair-fed or EtOH diet feeding. Yellow triangles indicate LepR+ADH1+ or LepR+ALDH2+ cells. Scale bars, 50 μm. (C) Representative flow cytometry histograms of WT BM-MSCs cultured for 14 days (D14) (left). Cells were treated with 100 mM EtOH for 3 or 6 hours (n=3/group). Cultured cells and conditioned medium were then collected and subjected to qRT-PCR or acetaldehyde measurement, respectively (right). (D) Heatmap showing qRT-PCR analysis of D14-cultured BM-MSCs treated with 100 mM EtOH for 6 hours (left). Each column represents pooled data from triplicated samples. A summarized diagram of EtOH-induced transcriptomic changes in BM-MSCs related to glutamate metabolism is shown (right). Mitochondrial ROS measurements of D14-cultured BM-MSC treated with 100 mM EtOH for 30 minutes w/o MitoTEMPO, a mitochondrial ROS scavenger (bottom). (E) D14-cultured BM-MSCs were treated with 100 mM EtOH for 48 hours and subjected to western blot analysis (left, 3 blots/group). Glutamate levels were measured in cultured media from BM-MSCs treated with 100 μM xCT inhibitor (sulfasalazine, SSZ) for 2 hours, followed by 100 mM EtOH for 6 hours (right, n=3/group). (F) Representative immunostaining of xCT in BM tissues and glutamate levels of the BM from WT mice subjected to Pair-fed or EtOH diet feeding. Blue triangles indicate xCT+ cells. Scale bars, 100 μm. Data are presented as mean±standard error of the mean. AU, arbitrary unit; BM-MSC, bone marrow mesenchymal stromal cells; GSH, glutathione; GSSG, glutathione disulfide; GSA, glutamate-γ-semialdehyde; LepR, leptin receptor; P5C, Δ1-pyrroline-5-carboxylate; ROS, reactive oxygen species; tSNE, t-distributed stochastic neighbor embedding; WT, wild-type. *P<0.05, **P<0.01, ***P<0.001.
To investigate alcohol-mediated metabolic changes in LepR+ MSCs, we cultured mouse BM-MSCs in vitro. By day 14, most cells expressed the specific markers of LepR+ MSCs (LepR+PDGFRα+CD105+Sca1+/-) [21]. EtOH treatment increased Adh1 and Aldh2 expression as well as acetaldehyde levels in the media (Fig. 2C; Supplementary Fig. 2C, 2D). Moreover, similar to hepatocytes [13], EtOH treatment to BM-MSCs elevated mitochondrial ROS and markedly increased the expression of GSH synthesis-related genes (Gclc, Gss, and Gsr) (Fig. 2D). It also elevated the expression of Gls and Slc7a11 (encoding xCT) and their protein levels (Fig. 2D, 2E), which exchange intracellular glutamate with extracellular cystine, leading to increased glutamate levels in the culture medium of BM-MSCs, but this effect was abrogated by the xCT inhibitor, sulfasalazine (SSZ) (Fig. 2E). Furthermore, xCT expression was significantly increased in perivascular cells in the BM by chronic alcohol intake, leading to increased BM glutamate levels (Fig. 2F). These findings suggest that chronic ethanol consumption triggers xCT-mediated glutamate excretion by LepR+ BM-MSCs, which in turn may regulate neighboring BM cells expressing mGluRs.
Chronic alcohol consumption promotes LepR+ MSCs to stimulate IFN-γ production in BM NK cells via mGluR5
To explore the target cells of glutamate in the BM, we screened for mGluRs in monocytes and lymphocytes and detected elevated expression of Grm1, Grm3, Grm4, Grm5, and Grm8 in lymphocytes than monocytes (Fig. 3A; Supplementary Fig. 3A). Next, we examined mGluR expression in each subtype of lymphocytes in Pair- or EtOH-fed mice. The results showed that while most of the other mGluRs were either decreased or remained unchanged in lymphocytes, Grm5 expression was significantly increased only in NK cells as well as their population after alcohol consumption (Fig. 3A; Supplementary Fig. 3B).
Figure 3.

Chronic ethanol intake promotes LepR+ MSCs-NK cell proximity, facilitating mGluR5-dependent IFN-γ production in BM. (A) qRT-PCR analyses for glutamate receptors in isolated monocytes and lymphocytes from WT BM (left, n=3), and isolated lymphocyte subsets from WT mice with Pair-fed or EtOH diet for 8 weeks (right, n=3/group). (B) scRNA-seq analysis of BM immune cells in WT mice (GSE132042). NK cells are shown with dotted lines (left). Flow cytometry analysis of CXCR3 expression from BM NK cells of WT mice fed a Pair-fed (n=8) or EtOH (n=6) diet for 8 weeks (middle, n=5/group). qRT-PCR analysis of isolated LepR+ BM-MSCs (right). (C) Representative NCR1 immunostaining of BM tissues of Lepr-cre x tdTomato mice fed with a Pair-fed or EtOH diet for 8 weeks (upper). D14-cultured BM-MSCs were pretreated with 100 mM EtOH for 6 hours and then co-cultured with isolated BM NK cells for 3 hours. Representative phase contrast images and qRT-PCR analysis of co-cultured BM-MSCs and NK cells (bottom, n=3/group). Yellow triangles indicate co-localization of LepR+ BM-MSCs and NCR1+ NK cells (upper) or close location of BM-MSCs and NK cells (bottom). Scale bars, 50 μm (upper), 100 μm (bottom). (D) mGluR5-expressing BM NK cells were treated with CHPG (10 μM) for 1 hour. Both the cells and their culture media were analyzed using flow cytometry, qRT-PCR and ELISA for IFN-γ production (bottom, n=3/group). (E) Flow cytometry analysis of IFN-γ-producing BM lymphocytes from IFN-γ reporter (GREAT) mice fed a Pair-fed or EtOH diet for 8 weeks (n=5/group). (F) Schematic illustration depicts spatial crosstalk between MSCs and NK cells within BM tissues following chronic alcohol consumption. The illustration was created with BioRender.com. Data are presented as mean±standard error of the mean. BM-MSC, bone marrow mesenchymal stromal cells; IFN-γ, interferon-γ; LepR, leptin receptor; NK, natural killer. *P<0.05, **P<0.01, ***P<0.001.
Given that the glutamate/mGluR signaling pathway generally occurs between closely positioned pre- and post-synaptic neurons, we explored the spatial interaction between LepR+ MSCs and NK cells in the BM. scRNA-seq analysis of BM immune cells from WT mice [22] revealed that NK cells primarily expressed Cxcr3 rather than Cxcr4, among chemokine receptors (Fig. 3B). In addition, we found that CXCR3 levels were significantly increased only in NK cells, while CXCR4 expression levels remained unchanged in all BM lymphocyte subsets following chronic alcohol exposure (Fig. 3B; Supplementary Fig. 3C). Moreover, we observed that the expression of CXCR3 ligands (Cxcl9 and Cxcl10) was upregulated in LepR+ MSCs in EtOH-fed mice (Fig. 3B). In line with these findings, NCR1+ NK cells were closely located with LepR+ MSCs in the perivascular region of BM in EtOH-fed mice compared to Pair-fed mice (Fig. 3C). Consistently, we performed co-culture experiments and found that pretreatment of EtOH to LepR+ MSCs promoted spatial proximity with isolated BM NK cells, elevating the expression levels of Cxcl9 and Cxcl10 in MSCs and Grm5 and Ifng in NK cells, respectively (Fig. 3C).
To confirm mGluR5-mediated IFN-γ production in BM NK cells, we treated CHPG, mGluR5-specific agonist, to BM NK cells and observed that Ifng expression in NK cells and its secretion into media were significantly upregulated upon mGluR5 stimulation, whereas the expression of Gzmb, Prf1, Fasl, and Tnfsf10 remained unchanged (Fig. 3D; Supplementary Fig. 3D). Similarly, direct glutamate treatment increased Ifng expression in NK cells in a dose-dependent manner, but it was abrogated by mGluR5 antagonist (Supplementary Fig. 3E). Consistently, among lymphocytes, only the frequency of IFN-γ+ BM NK cells in EtOH-fed IFN-γ reporter GREAT mice was significantly increased compared to Pair-fed mice (Fig. 3E). However, serum IFN-γ levels remained comparable between Pair- or EtOH-fed mice (Supplementary Fig. 3F), suggesting that glutamate-induced IFN-γ production by NK cells likely exerts only a paracrine effect within the BM niche. All these results indicate that the spatial proximity between LepR+ BM-MSCs and NK cells facilitates glutamate/mGluR5-induced IFN-γ production in NK cells in the context of chronic alcohol consumption (Fig. 3F).
IFN-γ licenses Ly6Clow BM monocytes to express IL-1R2 while suppressing CX3CR1, thereby facilitating their egress
Next, we explored the target cells and roles of IFN-γ produced by NK cells in the BM. Reanalysis of scRNA-seq data from WT mouse BM immune cells [22] revealed that Ifngr1 and Ifngr2, which encode the IFN-γ receptor subunits, were predominantly expressed in BM monocytes. They also expressed both Ccr2 and Cx3cr1, key genes involved in monocyte chemotaxis, whereas only Ccr2 expression was observed in hepatic IL-1R2+Ly6Clow macrophages from EtOH-fed mice (Fig. 4A). Indeed, flow cytometry analyses showed that CX3CR1 expression significantly decreased in both Ly6Clow BM monocytes and hepatic macrophages, despite comparable CCR2 expression after chronic alcohol consumption (Fig. 4B; Supplementary Fig. 4A). Simultaneously, IL-1R2 levels significantly increased in Ly6Clow BM monocytes from EtOH-fed mice compared to Pair-fed mice (Fig. 4C). These data suggest that IFN-γ may suppress Cx3cr1 expression while enhancing Il1r2 expression in BM monocytes under chronic alcohol exposure. To demonstrate this hypothesis, we investigated whether IFN-γ directly regulates expression of Cx3cr1 and Il1r2 in Ly6Clow BM monocytes. In isolated BM Ly6Clow monocytes, IFN-γ treatment markedly suppressed Cx3cr1 expression without affecting Ccr2, whereas it increased Il1r2 expression (Fig. 4D; Supplementary Fig. 4B). In line with this, we reanalyzed publicly available STAT1 ChIP-seq data from BM-derived macrophages treated with IFN-γ [23], and observed STAT1 binding at the Il1r2 locus near the transcription start site but not at the Cx3cr1 locus (Supplementary Fig. 4C), suggesting that IFN-γ/STAT1 might directly promote Il1r2 transcription, whereas it might indirectly suppress Cx3cr1 expression.
Figure 4.

IFN-γ licenses Ly6Clow BM monocytes to express IL-1R2 and suppresses CX3CR1 to expedite their egress. (A) Feature plots from scRNA-seq analysis of WT BM immune cells (GSE132042). Dotted lines highlight the monocyte population (left). scRNA-seq analysis of hepatic F4/80+CD11b+ macrophages from WT mice fed a Pair-fed or EtOH diet for 8 weeks. Dotted lines indicate the Ly6Clow_2 population (right). (B) Flow cytometry analysis of CX3CR1 expression of F4/80+CD11b+ BM monocytes (top) or hepatic macrophages (bottom) in WT mice fed a Pair-fed or EtOH diet for 8 weeks (n=5/group). (C) Flow cytometry analysis of IL-1R2 expression in F4/80+CD11b+ BM monocytes from WT mice subjected to a Pair-fed or EtOH diet for 8 weeks (n=5/group). (D) Sorted WT BM Ly6Clow monocytes were treated with IFN-γ for 3 hours and subjected to qRT-PCR analysis (n=3/group). (E) Feature plots for scRNA-seq of WT BM immune cells (GSE108892, left). D14-cultured BM-MSCs were exposed with 50 mM EtOH for 3 hours. eGFP+ BM monocytes were treated with IFN-γ (1 ng/mL) for 3 hours. After that, MSCs (plate well) and monocytes (Transwell® insert with 8 μm pore size) were indirectly co-cultured for 4 hours. Then, collected MSCs were subjected to qRT-PCR analysis (left bar graph). The number of migrated monocytes was counted in five random images at ×200 magnification (right bar graph). All experiments conducted in triplicate. (F) Schematic summary illustrates the egress mechanism of IL-1R2+Ly6Clow BM monocytes, driven by IFN-γ-mediated suppression of CX3CR1 and induction of IL-1R2. The illustration was created with BioRender.com. Data are presented as mean±standard error of the mean. BM-MSC, bone marrow mesenchymal stromal cells; eGFP, enhanced green fluorescent protein; IL-1R, interleukin-1 receptor; WT, wild-type. *P<0.05, **P<0.01, ***P<0.001.
Given that LepR+ MSC predominantly expressed Cx3cl1 among BM niche cells, and that its expression was upregulated following EtOH treatment (Fig. 4E; Supplementary Fig. 4D), we tested whether IFN-γ-mediated suppression of CX3CR1 in Ly6Clow BM monocytes could disrupt their chemotactic interaction with LepR+ MSCs. Using a Transwell system, isolated BM monocytes from eGFP mice were co-cultured in vitro with WT BM-MSCs. Prior to co-culture, both MSCs and monocytes were pretreated with EtOH or IFN-γ for 3 hours. After pretreatment, EtOH and IFN-γ were removed, and the cells subsequently were co-cultured for 4 hours (Fig. 4E). In qRT-PCR analysis, EtOH increased Cx3cl1 expression in BM-MSCs, regardless of co-culture (Fig. 4E). Consistent with this, many eGFP+ monocytes migrated to EtOH-treated BM-MSCs compared with the control. In contrast, IFN-γ pretreatment of BM monocytes significantly impaired their chemotactic recruitment toward BM-MSCs, regardless of EtOH pretreatment (Fig. 4E; Supplementary Fig. 4E). To further validate whether CX3CR1 is crucial for this migration, WT BM-MSCs were co-cultured with CX3CR1 knock-in (CX3CR1GFP/GFP) BM monocytes. Migration of CX3CR1GFP/GFP BM monocytes to WT BM-MSCs was not suppressed by IFN-γ (Supplementary Fig. 4F). These results suggest that NK cell-derived IFN-γ may facilitate intrahepatic migration of Ly6Clow monocytes from BM-MSCs by downregulating Cx3cr1 and upregulating Il1r2 expression (Fig. 4F).
Genetic ablation of xCT in Lepr+ MSCs exacerbates ALD through reducing IFN-γ expression in BM NK cells
To validate the above findings, Lepr-Cre mice were crossed with Slc7a11f/f mice (Slc7a11LepR) to genetically abolish xCT-mediated glutamate excretion in Lepr+ MSCs, followed by EtOH diet feeding. Upon chronic ethanol exposure, Slc7a11LepR mice exhibited significantly elevated serum levels of alanine aminotransferase (ALT), aspartate aminotransferase (AST), and IL-1β, while maintaining body weight and diet intake comparable to control mice (Fig. 5A; Supplementary Fig. 5A). In addition to steatosis, numbers of inflammatory foci and myeloperoxidase (MPO)+ neutrophils were increased in the liver of Slc7a11LepR mice, accompanied by elevated expression of Il1b and Il6 in liver mononuclear cells (MNCs) (Fig. 5B; Supplementary Fig. 5B). In Slc7a11LepR mice, BM NK cells showed reduced mGluR5 expression and IFN-γ production (Fig. 5C, 5D), highlighting the role of xCT-mediated glutamate secretion from LepR⁺ BM-MSCs in regulating mGluR5 and IFN-γ expression in NK cells. Accordingly, Ly6Clow BM monocytes expressed higher CX3CR1, while hepatic macrophages showed lower IL-1R2 in Slc7a11LepR mice compared with controls (Fig. 5E). However, there were no changes in CCR2 expression of hepatic macrophages (Supplementary Fig. 5C). Consequently, the frequencies of Ly6Clow monocytes were increased in the BM but reduced in the liver and blood of Slc7a11LepR mice compared with controls, indicating impaired egress of Ly6Clow monocytes from the BM (Fig. 5F; Supplementary Fig. 5D). Collectively, these findings demonstrate that the genetic inhibition of xCT in Lepr+ MSCs reduced IFN-γ production by BM NK cells and suppressed the egress of IL-1R2+Ly6Clow BM monocytes, thereby exacerbating ALD.
Figure 5.

Genetic deficiency of xCT in LepR+ MSCs exacerbates ALD with decreased IL-1R2 expression in hepatic Ly6Clow macrophages. Slc7a11f/f and Slc7a11LepR mice were fed with EtOH diet for 8 weeks (n=6/group). (A) Serum levels of ALT, AST, and IL-1β. (B) Representative H&E and MPO immunostaining of liver tissues. Yellow triangles indicate inflammatory foci or MPO+ cells. Scale bars, 50 μm. (C) A representative histogram of mGluR5 expression in BM NK cells. (D) IFN-γ-producing BM NK cells were analyzed by flow cytometry with representative plots. (E) Flow cytometry analysis for CX3CR1 in F4/80+CD11b+ BM monocytes (left) and IL-1R2 (right) in F4/80+CD11b+ hepatic macrophages with representative plots. (F) The frequencies of Ly6Chigh and Ly6Clow BM monocytes (left) and hepatic macrophages (right) were analyzed by flow cytometry. Data are presented as mean±standard error of the mean. ALT, alanine aminotransferase; AST, aspartate aminotransferase; BM, bone marrow; IL-1R, interleukin-1 receptor; LepR, leptin receptor; NK, natural killer. *P<0.05, **P<0.01, ***P<0.001.
mGluR5 deficiency in NK cells lowers Il1r2 expression in hepatic Ly6Clow macrophages, and blocking IL-1β signaling limits ALD
Based on the above findings, NK cell-specific mGluR5 knock-out (Grm5NK) mice were fed an EtOH diet. At sacrifice, there were no differences in body weight gain, mean dietary intake and CXCR3 expression in BM lymphocytes between the two groups (Supplementary Fig. 6A, 6B). However, the frequencies and numbers of IFN-γ⁺ NK cells were markedly reduced in the BM and blood of Grm5NK mice compared with controls (Fig. 6A). Deficiency of mGluR5 in NK cells led to elevated serum levels of ALT and IL-1β, accompanied by increased infiltration of MPO⁺ neutrophils and inflammatory foci, as well as enhanced expression of Il1b and Il6 in liver MNCs (Fig. 6B, 6C; Supplementary Fig. 6C, 6D). In addition, the frequency of F4/80+CD11b+Ly6Clow monocytes was decreased in liver tissue of Grm5NK mice compared with controls (Fig. 6C), along with significantly decreased IL-1R2 expression in hepatic F4/80+CD11b+Ly6Clow macrophages (Supplementary Fig. 6E). These results highlight the critical role of mGluR5 in BM NK cells in regulating IL-1R2 expression in Ly6Clow macrophages and resisting IL-1β-mediated ALD.
Figure 6.

mGluR5 depletion in NK cells lowers IL-1R2 expression in hepatic Ly6Clow macrophages, while recombinant IL-1R2 alleviates ALD. (A–C) Grm5f/f and Grm5NK mice were fed EtOH diet for 8 weeks (n=6/group). (A) IFN-γ-producing BM NK cells were analyzed by flow cytometry with representative plots. (B) Serum levels of ALT and IL-1β. (C) Flow cytometry analyses of hepatic macrophages and their IL-1R2 expression (right). H&E and MPO immunostaining of liver tissues (left). MPO+ neutrophils were counted at ×200 magnification (n=6/group). Yellow triangles indicate inflammatory foci or MPO+ neutrophils. Scale bars, 50 μm. (D–G) During EtOH diet feeding, WT mice were intraperitoneally injected with recombinant mouse IL-1R2 (rcIL-1R2) (0.1 mg/kg) for consecutive 3 days before oral gavage of 4 g/kg of 40% ethanol (n=6/group). (D) Serum levels of ALT, AST and IL-1β in Veh or rcIL-1R2-treated mice. (E) Western blotting using whole liver tissues of Veh or rcIL-1R2-treated mice. (F) Flow cytometry analysis for frequencies of F4/80+CD11b+ macrophages with representative plots. (G) Liver tissues were stained with MPO antibody and the TUNEL kit. MPO+ neutrophils and apoptotic cells were counted in immunostaining of liver tissues at ×200 magnification (n=6/group). Scale bars, 50 μm. Data are presented as mean±standard error of the mean. ALD, alcohol-associated liver disease; ALT, alanine aminotransferase; AST, aspartate aminotransferase; BM, bone marrow; IL-1β, interleukin-1β; IL-1R, interleukin-1 receptor; NK, natural killer; WT, wild-type. *P<0.05, **P<0.01, ***P<0.001.
To evaluate the therapeutic potential of IL-1R2 in ASH [24], we administered either vehicle (saline) or recombinant mouse IL-1R2 (rcIL-1R2, 0.1 mg/kg) intraperitoneally for three consecutive days prior to binge drinking (Fig. 6D). At sacrifice, without any differences of body weight change and diet intake (Supplementary Fig. 6F), rcIL-1R2-treated mice exhibited significantly lower levels of ALT, AST, and IL-1β, along with reduced hepatic levels of cleaved caspase-1 and IL-1β, compared with vehicle-treated controls (Fig. 6D, 6E). Furthermore, in rcIL-1R2-treated livers, the numbers of F4/80⁺CD11b⁺ macrophages, MPO⁺ neutrophils, inflammatory foci, and apoptotic cells were markedly reduced relative to controls, whereas CYP2E1 expression remained comparable between groups (Fig. 6F, 6G; Supplementary Fig. 6G). Collectively, these results suggest that IL-1R2 in macrophages may confer protection against ASH.
IL-1R2 elevation is a conserved feature among patients with ASL
To assess whether this mechanism is conserved in patients, we measured plasma IL-1R2 levels in healthy controls and individuals diagnosed with ASL and ALC (Supplementary Table 1). Consistently, plasma IL-1R2 levels were significantly higher in patients with ASL and ALC than in healthy controls, while patients with ASL and ALC exhibited comparable levels (Fig. 7A). In addition, plasma IL-1R2 levels positively correlated with γ-glutamyl transferase (GGT) levels but not with AST/ALT ratio or the number of white blood cells (Fig. 7A).
Figure 7.

IL-1R2 elevation is detected in patients with early-stage alcohol-associated liver disease (ALD). Peripheral blood samples were collected from healthy controls (HCs, n=13), patients with alcohol-associated steatotic liver (ASL, n=19), and alcohol-associated cirrhosis (ALC, n=16), and subsequently analyzed (Supplementary Table 1). (A) Plasma levels of IL-1R2 and correlation analysis of plasma IL-1R2 levels with γ-glutamyl transferase (GGT), AST/ALT ratio, and white blood cell (WBC) counts. (B) Flow cytometry analyses of neutrophils and monocytes from isolated PBMCs in ALD patients. The frequencies and IL-1R2 expression levels in CD14+CD16+ non-classical monocytes (red rectangle), CD14hiCD16+ intermediate monocytes (black rectangle), and CD14hiCD16- classical monocytes (green rectangle) in isolated peripheral blood mononuclear cells (PBMCs) with representative histograms. (C) Flow cytometry analysis of IL-1R2 expression in CD11b+CD15+ neutrophils. (D) PBMCs were isolated, and CD14hiCD16- classical monocytes (green rectangle) or CD16+ intermediate and non-classical monocytes (red rectangle) were sorted from patients with ASL and ALC. qRT-PCR was performed for IL1R2 expression (n=3/group). (E) Representative immunostaining of liver tissues of HC and patients with alcohol-associated steatohepatitis (ASH). Yellow empty triangles indicate IL-1R2+ cells. (F) Human monocyte-derived macrophages (hMDMs) were treated with IFN-γ (10 ng/mL) for the indicated times, followed by analysis of IL1R2 and CX3CR1 mRNA expression by qPCR and CX3CR1 surface expression by flow cytometry. qRT-PCR analysis and CX3CR1 expression in hMDMs. hMDMs were treated with 10 ng/mL IFN-γ for 1 or 3 hours. Scale bars, 50 μm. Data are presented as mean±standard error of the mean. ALT, alanine aminotransferase; AST, aspartate aminotransferase; IL-1R, interleukin- 1 receptor; ns, not significant.*P<0.05, ***P<0.001.
To identify the primary cellular source of IL-1R2, we assessed its expression in peripheral blood mononuclear cell (PBMC) subsets, including CD14+CD16+ non-classical monocytes, CD14hiCD16+ intermediate monocytes, CD14hiCD16- classical monocytes, and CD11b+CD15+ neutrophils (Supplementary Fig. 7A). Although the frequencies of blood monocyte subsets were comparable across groups, patients with ASL exhibited significantly higher IL-1R2 expression in CD14+CD16+ non-classical and CD14hiCD16+ intermediate monocytes, while no differences were observed in CD14hiCD16- classical monocytes or CD11b+CD15+ neutrophils (Fig. 7B, 7C). Furthermore, isolated CD16+ monocytes from ASL patients showed higher IL1R2 expression compared to CD14hiCD16- classical monocytes (Fig. 7D). Consistent with these findings, IL-1R2+ cells were prominently detected in liver tissues of ASH patients (Fig. 7E). However, because monocyte phenotyping was restricted to peripheral blood, no differences in CX3CR1 and CCR2 expression were observed across monocyte subsets, except for a slight elevation of CX3CR1 in CD14hiCD16+ intermediate monocytes from ASL patients (Supplementary Fig. 7B, 7C). Consistent with these findings, in vitro IFN-γ treatment increased the expression of IL1R2 but not CX3CR1 in human monocyte-derived macrophage (hMDM) at 1 hour, whereas it decreased protein levels of CX3CR1 in hMDM at 3 hours (Fig. 7F). Collectively, these findings indicate that the increase of IL-1R2+ monocytes is a consistent feature that contributes to anti-inflammatory responses at the early stage of ALD.
DISCUSSION
Although IL-1β–driven liver inflammation is a critical factor in the progression of ASH, chronic ethanol consumption most often results in ASL rather than ASH, despite elevated IL-1β levels [1,2,25]. This paradox suggests the existence of a protective mechanism that suppresses IL-1β signaling. In line with this, our recent study demonstrated that during prolonged alcohol exposure, catecholamines inhibit inflammatory signaling, including IL-1β, through the death of inflammatory Kupffer cells, thereby mitigating the progression from ASL to ASH [26]. In this study, we observed increased hepatic inflammation even in the ASL model following genetic ablation of xCT in LepR+ BM-MSCs or mGluR5 in BM NK cells. This effect was linked to reduced intrahepatic migration of IL-1R2⁺Ly6Clow macrophages, likely due to unchanged CX3CR1 expression. These findings suggest that crosstalk between the liver and BM—through the triadic interplay of metabolic (alcohol metabolism in LepR⁺ BM-MSCs), neurological (mGluR5 signaling in NK cells), and immune (CX3CR1 regulation in Ly6Clow monocytes) pathways—acts as an inflammatory checkpoint that preserves hepatic homeostasis and limits the progression from ASL to ASH.
It is generally recognized that hepatic injuries from chronic alcohol consumption arise not only from the direct toxic effects of alcohol itself, but also from gut-derived portal delivery of pathogen- or damage-associated molecular patterns due to intestinal leakage [27]. However, recent studies have emphasized that ALD also involves additional interorgan crosstalk, including interactions with BM and adipose tissue [6]. In liver injury, the BM-liver axis represents a distinct and complementary regulatory layer, governing the upstream generation, mobilization, and trafficking of inflammatory myeloid cells from the BM to the liver. The novelty of our study lies in demonstrating that the BM functions not merely as a passive reservoir of immune cells, but as an active regulator of hepatic inflammation by modulating myeloid cell output and macrophage accumulation in the injured liver. This conceptual framework extends beyond the conventional gut-liver axis by highlighting the regulation of monocyte phenotype that migrates to the liver and drive anti-inflammatory responses, thereby suggesting new therapeutic opportunities targeting BM-derived immune cell programming and trafficking.
Additionally, excessive alcohol consumption can exert toxic effects on BM hematopoiesis and the peripheral monocyte pool [28], indicating that orally ingested alcohol reaches and influences the BM niche. In contrast, under chronic low-dose exposure, perisinusoidal LepR+ BM-MSCs exhibited beneficial roles by inducing alcohol-metabolizing enzymes. In LepR+ BM-MSCs, alcohol metabolism upregulated Cx3cl1 expression, facilitating the recruitment of Ly6Clow monocytes, which express relatively higher levels of CX3CR1 compared to Ly6Chigh monocytes [29], to the perisinusoidal area. Concurrently, chronic alcohol exposure increased Slc7a11, Cxcl9, and Cxcl10 expression in LepR+ BM-MSCs, fostering spatial proximity with CXCR3+ BM NK cells. This interaction enhanced mGluR5-mediated IFN-γ production in NK cells and promoted Ly6Clow monocytes egress through downregulation of CX3CR1. Collectively, these results highlight a novel safeguarding role of neurological signaling pathways among non-neuronal cells within the perisinusoidal BM niche in ALD, supporting the emerging concept of glutamate as a neurotransmitter beyond the central nervous system [13,14,30,31].
Both membrane-bound and soluble IL-1R2 are well established to suppress IL-1 signaling primarily by functioning as a decoy receptor (“molecular trap”) that reduces IL-1β bioavailability [32,33]. Consistent with this mechanism, in our IL-1R2 intervention experiment, we observed lower serum IL-1β levels in mice following acute-on-chronic alcohol exposure. In addition to ligand sequestration, IL-1R2 has been reported to suppress NF-κB pathway activation (a key priming step for pro–IL-1β induction in the NLRP3 inflammasome cascade) in the presence of IL-1RAcP [32]. Accordingly, our scRNA-seq analysis shows that the IL-1R2highLy6Clow_2 monocyte subset expresses relatively lower levels of NF-κB signaling–associated genes (e.g., Myd88, Irak4, Traf6) compared with other monocyte clusters. Therefore, we propose the intervention effects of rcIL-1R2 treatment in mice with early stage of ALD. Similarly, previous preclinical studies have shown that pharmacological inhibition of IL-1β signaling with the recombinant IL-1 receptor antagonist (IL-1Ra) anakinra effectively attenuates ALD progression in experimental models [25]. However, clinical trials in patients with severe alcohol-associated hepatitis reported that combinatorial treatment of anakinra with or without pentoxifylline resulted in similar or lower survival compared with methylprednisolone or prednisone [34]. In our study, IL-1R2+CD14+CD16+ non-classical blood monocytes were significantly elevated only in patients with ASL, but not in those with ALC. These findings suggest that the anti-inflammatory role of IL-1R2 may be most effective in the early stages of ALD. Moreover, the positive correlation between plasma IL-1R2 and GGT levels in ASL patients supports the potential of IL-1R2 as both a diagnostic marker and therapeutic target in early ALD. Additionally, a study has shown that reduced NK cell activity and increased hepatic IL-1β expression after chronic alcohol consumption are reversed by the administration of gut microbiota [35], suggesting that the gut microbiome may alleviate ALD by regulating immune cells when IL-1R2+ macrophages are reduced. Furthermore, IFN-γ has been considered as a pro-inflammatory cytokine, but it also exhibits anti-inflammatory properties [36]. In our study, we observed that IFN-γ treatment induced IL-1R2 expression in Ly6Clow BM monocytes. Given the potential anti-inflammatory role of IFN-γ and its regulation of IL-1R2 expression in Ly6Clow monocytes, further investigation into the underlying mechanisms is warranted.
In summary, our findings suggest a protective mechanism within the BM-liver axis that prevents progression from ASL to ASH by promoting hepatic recruitment of IL-1R2+Ly6Clow monocytes. These findings provide novel insight into the BM-liver axis as an inflammatory checkpoint in alcohol-associated inflammation and highlight its potential to be harnessed for preventing the progression of ALD.
Abbreviations
- ADH1
alcohol dehydrogenase 1
- AH
alcohol-associated hepatitis
- ALC
alcohol-associated liver cirrhosis
- ALD
alcohol-associated liver disease
- ALDH2
acetaldehyde dehydrogenase 2
- ASL
alcohol-associated steatotic liver
- ASH
alcohol-associated steatohepatitis
- BM
bone marrow
- CCR2
C-C chemokine receptor type 2
- CXCR
C-X-C motif chemokine receptor
- CXCL
C-X-C motif chemokine ligand
- CX3CR1
fractalkine receptor
- CYP2E1
cytochrome P450 2E1
- eGFP
enhanced green fluorescent protein
- EtOH
ethanol
- GGT
γ-glutamyl transferase
- GSH
glutathione
- GREAT
interferon-γ reporter with endogenous polyA transcript
- IL-1β
interleukin-1β
- IL-1R
interleukin-1 receptor
- IL-1Ra
interleukin-1 receptor antag onist
- IFN-γ
interferon-γ
- LepR
leptin receptor
- mGluR
metabotropic glutamate receptor
- MNC
mononuclear cell
- MSC
mesenchymal stromal cell
- MSG
monosodium glutamate
- NK
natural killer
- Pair
isocaloric maltose-dextrin
- PBMC
peripheral blood mononuclear cell
- PDGFRα
platelet-derived growth factor receptor-α
- rcIL-1R2
recombinant mouse IL-1R2
- ROS
reactive oxygen species
- scRNA-seq
single-cell RNA sequencing
- SSZ
sulfasalazine
- WT
wild-type
Study Highlights
• Chronic alcohol consumption increases IL-1R2 expression in Ly6Clow hepatic macrophages in mice and CD14+CD16+ blood monocytes in humans.
• Alcohol metabolism in LepR+ BM-MSCs enhances xCT-dependent glutamate excretion, driving CXCL9/10-mediated NK cell recruitment.
• Activation of mGluR5 in NK cells induces IFN-γ production, which upregulates IL-1R2 and suppresses CX3CR1 in neighboring Ly6Clow monocytes, thereby facilitating their migration to the liver.
• Disruption of xCT in BM-MSCs or mGluR5 in BM NK cells aggravates ALD and impairs hepatic migration of IL-1R2+Ly6Clow monocytes, whereas recombinant IL-1R2 ameliorates ALD, highlighting the therapeutic potential of IL-1R2 or IL-1R2+ monocytes in preventing ALD progression.
Footnotes
Authors’ contribution
YRS and YSL designed the study and wrote the first draft of the manuscript. HHK and MJK contributed to manuscript editing and review. YRS, HHK, MJK, JHL, KK, SEC, KPSC, EL, KWL, JB, JO, JMH, and JHB prepared animals, performed experiments and analyzed the data. YSL and WK provided and analyzed patient samples. JEP performed initial analysis of scRNA-seq data. YSL and WIJ edited the manuscript, secured funding and supervised the study.
Acknowledgements
This work was supported by grants from the National Research Foundation of Korea (NRF), funded by the Korean government (MSIT) (RS-2021-NR059919, RS-2022-NR067269, RS-2023-00223831) and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (RS-2025-25458964, RS-2024-00439963). The AI tool was employed solely for linguistic assistance. The illustration was created in https://BioRender.com.
Conflicts of Interest
The authors have no conflicts to disclose.
SUPPLEMENTARY MATERIAL
Supplementary material is available at Clinical and Molecular Hepatology website (http://www.e-cmh.org).
Hepatic Ly6Clow macrophages in EtOH-fed mice show reduced expression of IL-1β signaling-related genes compared to those in Pair-fed mice. WT mice were fed either a Pair-fed or EtOH diet for 8 weeks (n=6/group). (A) Isolation of liver MNCs and gating strategies of F4/80+CD11b+ macrophages for scRNA-seq analysis. (B) UMAP feature plots showing the expression of the indicated macrophage marker genes in hepatic macrophages. (C) Violin plots illustrating the expression of IL-1β signaling-related genes in hepatic macrophages, as analyzed by scRNA-seq. (D) Serum levels of ALT and AST in Pair- or EtOH-fed mice. (E) Representative Oil- Red O staining of liver tissues. Portal triad (PT) and central vein (CV). Scale bars, 50 μm.
EtOH exposure increases the expression of alcohol dehydrogenase 1 (ADH1) in cultured primary PDGFRα+LepR+ BM-MSCs. (A) Feature plots for scRNA-seq of BM niche in control WT mice (GSE108892) (left), and representative H&E and CYP2E1 immunostaining images of the BM of WT mice fed either a Pair-fed or EtOH diet for 8 weeks (right). Yellow triangles indicate BM-MSCs. Scale bars, 100 μm. (B) Gating strategies of mouse PDGFRα+LepR+ BM-MSCs with representative plots. (C) Representative phase-contrast (left) and immunostaining (right) images of BM-MSCs cultured for 14 days (D14). Scale bars, 50 μm (left), 100 μm (right). (D) Representative immunostaining images of D14-cultured BM-MSCs after 100 mM EtOH for 48 hours. Scale bars, 50 μm. ADH1, alcohol dehydrogenase 1; CYP2E1, cytochrome P450 2E1; LepR, leptin receptor; PDGFRα, platelet-derived growth factor receptor alpha.
Alteration in mGluR expression and phenotypic characteristics of BM lymphocytes following chronic alcohol consumption. (A) qRT-PCR analysis for metabotropic glutamate receptors (mGluRs) in monocytes and lymphocytes including CD4 T, CD8 T, NK, and NKT cells isolated from WT BM fed either a Pair-fed or EtOH diet for 8 weeks (n=3/group). (B, C) Flow cytometric analysis of frequency changes in BM lymphocytes, with representative histograms and quantification of CXCR3 and CXCR4 expression, in WT mice fed a Pair-fed or EtOH diet for 8 weeks (n=5/group). (D) Isolated BM NK cells from WT mice were treated with mGluR5-specific agonist CHPG (10 μM) for 30 minutes and subjected to qRT-PCR analysis (n=3/group). (E) Expression of Ifng in BM NK cells after treatments with glutamate w/o mGluR5 antagonist (CTEP). (F) Serum IFN-γ levels were measured (n=5/group). Data are presented as mean±standard error of the mean. *P<0.05, **P<0.01, ***P<0.001. Not detected (n.d.).
EtOH exposure upregulates CX3CL1 expression in BM-MSCs and enhances the migration of BM monocytes toward BM-MSCs, whereas IFN-γ significantly inhibits this migration. (A) Flow cytometry analysis for the surface expression of CCR2 in hepatic macrophages and BM monocytes of WT mice fed a Pair-fed or EtOH diet for 8 weeks, with representative histograms (n=5/ group). (B) qRT-PCR analysis for Ccr2 expression in Ly6Clow BM monocytes treated with IFN-γ for 3 hours. (C) STAT1 chromatin immunoprecipitation sequencing (ChIP-seq) analysis of mouse BM-derived macrophages (GSE115433). TSS, transcription start site. (D) qRTPCR analysis for Cx3cl1 expression in BM-MSCs exposed to EtOH for 9 hours. (E, F) BM MSCs were isolated from WT mice and cultured for 14 days followed by vehicle (PBS) or ethanol (50 mM) for 3 hours. BM monocytes were sorted from eGFP mice (E) or WT or CX3CR1GFP/GFP mice (F) and treated with vehicle (PBS) or IFN-γ (1 ng/mL) for 3 hours. (E) Migration assay of IFN-γ-treated eGFP+ BM monocytes to EtOH-exposed BM-MSCs. Scale bars, 50 μm. (F) Schematic summary of experimental setting (top). The number of migrated monocytes was measured (bottom). Data are presented as mean±standard error of the mean. *P<0.05, **P<0.01, ***P<0.001.
Genetic ablation of xCT in LepR+ MSCs increases inflammatory gene expression in liver MNCs and reduces blood Ly6Clow monocytes upon chronic alcohol intake. Slc7a11f/f and Slc7a11LepR mice were fed EtOH diet for 8 weeks (n=6/group). (A) Body weight changes and mean dietary intake. (B) qRT-PCR analysis of isolated liver MNCs (n=3/group). (C) Flow cytometry analysis for CCR2 expression in F4/80+CD11b+ hepatic macrophages. Black dashed line indicates the values of isotype controls. (D) Flow cytometry analysis for F4/80+CD11b+ blood monocytes. Data are presented as mean±standard error of the mean. *P<0.05, **P<0.01.
NK cell-specific mGluR5 deficiency exacerbates alcohol-associated liver injury, but recombinant IL-1R2 treatment attenuates ALD. (A–E) Grm5f/f and Grm5NK mice were fed an EtOH diet for 8 weeks (n=6/group). (A) Body weight changes and mean dietary intake. (B) Flow cytometry analysis for CXCR3 expression in BM lymphocytes with representative histograms. (C) Inflammatory foci were counted in liver tissues after H&E staining. (D) qRT-PCR analysis of isolated liver MNCs (n=3/group). (E) The frequencies and IL-1R2 expression of Ly6Chigh and Ly6Clow hepatic macrophages were analyzed by flow cytometry analysis. (F, G) WT mice were fed a 5% EtOH diet for 8 days and then randomly divided into two groups. Each group was intraperitoneally injected either with recombinant IL-1R2 (rcIL-1R2) (0.1 mg/kg) or vehicle (Veh) for 3 consecutive days, immediately prior to oral gavage with 4 g/kg of 40% EtOH (n=6 per group). (F) Body weight changes and mean dietary intake. (G) Representative CYP2E1 immunofluorescence staining and H&E staining of liver tissues from Veh- or rcIL-1R2-treated mice, with quantification of inflammatory foci. Scale bars, 50 μm. Data are presented as mean±standard error of the mean. *P<0.05, **P<0.01, ***P<0.001.
The frequencies of neutrophils and monocytes in the peripheral blood of patients with ALD remain unchanged. Peripheral blood samples from healthy controls (HCs; n=13) or patients with alcohol-associated steatotic liver (ASL; n=19) or alcohol-associated liver cirrhosis (ALC; n=16) were collected and analyzed (Supplementary Table 1). (A) Gating strategies and flow cytometric analysis for blood CD14+CD16+ non-classical (red rectangular), CD14hiCD16+ intermediate (black rectangular), and CD14hiCD16- classical (green rectangular) monocytes as well as CD11b+CD15+ neutrophils. (B, C) Flow cytometric analysis for CX3CR1 (B) and CCR2 (C) expression of blood monocytes. Data are presented as mean±standard error of the mean. *P<0.05.
Clinical characteristics of healthy controls and patients with alcohol-associated liver diseases
The list of antibodies
Primer sequences for qPCR
REFERENCES
- 1.Seitz HK, Bataller R, Cortez-Pinto H, Gao B, Gual A, Lackner C, et al. Alcoholic liver disease. Nat Rev Dis Primers. 2018;4:16. doi: 10.1038/s41572-018-0014-7. [DOI] [PubMed] [Google Scholar]
- 2.Szabo G, Petrasek J. Inflammasome activation and function in liver disease. Nat Rev Gastroenterol Hepatol. 2015;12:387–400. doi: 10.1038/nrgastro.2015.94. [DOI] [PubMed] [Google Scholar]
- 3.Peters VA, Joesting JJ, Freund GG. IL-1 receptor 2 (IL-1R2) and its role in immune regulation. Brain Behav Immun. 2013;32:1–8. doi: 10.1016/j.bbi.2012.11.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Li YH, Zhang Y, Pan G, Xiang LX, Luo DC, Shao JZ. Occurrences and functions of Ly6C(hi) and Ly6C(lo) macrophages in health and disease. Front Immunol. 2022;13:901672. doi: 10.3389/fimmu.2022.901672. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5.Ju C, Mandrekar P. Macrophages and alcohol-related liver inflammation. Alcohol Res. 2015;37:251–262. doi: 10.35946/arcr.v37.2.09. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Shim YR, Jeong WI. Recent advances of sterile inflammation and inter-organ cross-talk in alcoholic liver disease. Exp Mol Med. 2020;52:772–780. doi: 10.1038/s12276-020-0438-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Wang PP, Wang JH, Yan ZP, Hu MY, Lau GK, Fan ST, et al. Expression of hepatocyte-like phenotypes in bone marrow stromal cells after HGF induction. Biochem Biophys Res Commun. 2004;320:712–716. doi: 10.1016/j.bbrc.2004.05.213. [DOI] [PubMed] [Google Scholar]
- 8.Fausto N. Liver regeneration and repair: hepatocytes, progenitor cells, and stem cells. Hepatology. 2004;39:1477–1487. doi: 10.1002/hep.20214. [DOI] [PubMed] [Google Scholar]
- 9.Le Blanc K, Mougiakakos D. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol. 2012;12:383–396. doi: 10.1038/nri3209. [DOI] [PubMed] [Google Scholar]
- 10.Emoto T, Lu J, Sivasubramaniyam T, Maan H, Khan AB, Abow AA, et al. Colony stimulating factor-1 producing endothelial cells and mesenchymal stromal cells maintain monocytes within a perivascular bone marrow niche. Immunity. 2022;55:862–878.e8. doi: 10.1016/j.immuni.2022.04.005. [DOI] [PubMed] [Google Scholar]
- 11.Derecka M, Herman JS, Cauchy P, Ramamoorthy S, Lupar E, Grün D, et al. EBF1-deficient bone marrow stroma elicits persistent changes in HSC potential. Nat Immunol. 2020;21:261–273. doi: 10.1038/s41590-020-0595-7. [DOI] [PubMed] [Google Scholar]
- 12.Stavely R, Nurgali K. The emerging antioxidant paradigm of mesenchymal stem cell therapy. Stem Cells Transl Med. 2020;9:985–1006. doi: 10.1002/sctm.19-0446. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Choi WM, Kim HH, Kim MH, Cinar R, Yi HS, Eun HS, et al. Glutamate signaling in hepatic stellate cells drives alcoholic steatosis. Cell Metab. 2019;30:877–889.e7. doi: 10.1016/j.cmet.2019.08.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14.Kim HH, Shim YR, Kim HN, Yang K, Ryu T, Kim K, et al. xCT-mediated glutamate excretion in white adipocytes stimulates interferon-γ production by natural killer cells in obesity. Cell Rep. 2023;42:112636. doi: 10.1016/j.celrep.2023.112636. [DOI] [PubMed] [Google Scholar]
- 15.Choi WM, Ryu T, Lee JH, Shim YR, Kim MH, Kim HH, et al. Metabotropic glutamate receptor 5 in natural killer cells attenuates liver fibrosis by exerting cytotoxicity to activated stellate cells. Hepatology. 2021;74:2170–2185. doi: 10.1002/hep.31875. [DOI] [PubMed] [Google Scholar]
- 16.Askenase MH, Han SJ, Byrd AL, Morais da Fonseca D, Bouladoux N, Wilhelm C, et al. Bone-marrow-resident NK cells prime monocytes for regulatory function during infection. Immunity. 2015;42:1130–1142. doi: 10.1016/j.immuni.2015.05.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Jacquelin S, Licata F, Dorgham K, Hermand P, Poupel L, Guyon E, et al. CX3CR1 reduces Ly6Chigh-monocyte motility within and release from the bone marrow after chemotherapy in mice. Blood. 2013;122:674–683. doi: 10.1182/blood-2013-01-480749. [DOI] [PubMed] [Google Scholar]
- 18.Giunti D, Parodi B, Usai C, Vergani L, Casazza S, Bruzzone S, et al. Mesenchymal stem cells shape microglia effector functions through the release of CX3CL1. Stem Cells. 2012;30:2044–2053. doi: 10.1002/stem.1174. [DOI] [PubMed] [Google Scholar]
- 19.Araujo David B, Andreata F, Blériot C, Ginhoux F, Kubes P, Iannacone M. Kupffer cells in liver homeostasis and disease: from immune sentinels to metabolic gatekeepers. Nat Rev Immunol. 2026;26:538–554. doi: 10.1038/s41577-026-01288-0. [DOI] [PubMed] [Google Scholar]
- 20.Tikhonova AN, Dolgalev I, Hu H, Sivaraj KK, Hoxha E, Cuesta-Domínguez Á, et al. The bone marrow microenvironment at single-cell resolution. Nature. 2019;569:222–228. doi: 10.1038/s41586-019-1104-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Zhou BO, Yue R, Murphy MM, Peyer JG, Morrison SJ. Leptinreceptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell. 2014;15:154–168. doi: 10.1016/j.stem.2014.06.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Tabula Muris Consortium. Overall coordination. Logistical coordination. Organ collection and processing. Library preparation and sequencing. Computational data analysis. Cell type annotation. Writing group. Supplemental text writing group. Principal investigators Single-cell transcriptomics of 20 mouse organs creates a Tabula Muris. Nature. 2018;562:367–372. doi: 10.1038/s41586-018-0590-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Platanitis E, Demiroz D, Schneller A, Fischer K, Capelle C, Hartl M, et al. A molecular switch from STAT2-IRF9 to ISGF3 underlies interferon-induced gene transcription. Nat Commun. 2019;10:2921. doi: 10.1038/s41467-019-10970-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Bertola A, Mathews S, Ki SH, Wang H, Gao B. Mouse model of chronic and binge ethanol feeding (the NIAAA model) Nat Protoc. 2013;8:627–637. doi: 10.1038/nprot.2013.032. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, et al. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest. 2012;122:3476–3489. doi: 10.1172/JCI60777. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Kim HH, Shim YR, Choi SE, Kim MH, Lee G, You HJ, et al. Catecholamine induces Kupffer cell apoptosis via growth differentiation factor 15 in alcohol-associated liver disease. Exp Mol Med. 2023;55:158–170. doi: 10.1038/s12276-022-00921-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Szabo G. Gut-liver axis in alcoholic liver disease. Gastroenterology. 2015;148:30–36. doi: 10.1053/j.gastro.2014.10.042. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28.Ballard HS. The hematological complications of alcoholism. Alcohol Health Res World. 1997;21:42–52. [PMC free article] [PubMed] [Google Scholar]
- 29.Geissmann F, Jung S, Littman DR. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity. 2003;19:71–82. doi: 10.1016/s1074-7613(03)00174-2. [DOI] [PubMed] [Google Scholar]
- 30.Julio-Pieper M, Flor PJ, Dinan TG, Cryan JF. Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues. Pharmacol Rev. 2011;63:35–58. doi: 10.1124/pr.110.004036. [DOI] [PubMed] [Google Scholar]
- 31.Yang K, Kim K, Ryu T, Shim YR, Kim HH, Choi SE, et al. Binge drinking triggers VGLUT3-mediated glutamate secretion and subsequent hepatic inflammation by activating mGluR5/NOX2 in Kupffer cells. Nat Commun. 2025;16:5546. doi: 10.1038/s41467-025-60820-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Smith DE, Hanna R, Friend D, Moore H, Chen H, Farese AM, et al. The soluble form of IL-1 receptor accessory protein enhances the ability of soluble type II IL-1 receptor to inhibit IL-1 action. Immunity. 2003;18:87–96. doi: 10.1016/s1074-7613(02)00514-9. [DOI] [PubMed] [Google Scholar]
- 33.Garlanda C, Dinarello CA, Mantovani A. The interleukin-1 family: back to the future. Immunity. 2013;39:1003–1018. doi: 10.1016/j.immuni.2013.11.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Szabo G, Mitchell M, McClain CJ, Dasarathy S, Barton B, McCullough AJ, et al. IL-1 receptor antagonist plus pentoxifylline and zinc for severe alcohol-associated hepatitis. Hepatology. 2022;76:1058–1068. doi: 10.1002/hep.32478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Eom JA, Jeong JJ, Han SH, Kwon GH, Lee KJ, Gupta H, et al. Gut-microbiota prompt activation of natural killer cell on alcoholic liver disease. Gut Microbes. 2023;15:2281014. doi: 10.1080/19490976.2023.2281014. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Mühl H, Pfeilschifter J. Anti-inflammatory properties of proinflammatory interferon-gamma. Int Immunopharmacol. 2003;3:1247–1255. doi: 10.1016/S1567-5769(03)00131-0. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Hepatic Ly6Clow macrophages in EtOH-fed mice show reduced expression of IL-1β signaling-related genes compared to those in Pair-fed mice. WT mice were fed either a Pair-fed or EtOH diet for 8 weeks (n=6/group). (A) Isolation of liver MNCs and gating strategies of F4/80+CD11b+ macrophages for scRNA-seq analysis. (B) UMAP feature plots showing the expression of the indicated macrophage marker genes in hepatic macrophages. (C) Violin plots illustrating the expression of IL-1β signaling-related genes in hepatic macrophages, as analyzed by scRNA-seq. (D) Serum levels of ALT and AST in Pair- or EtOH-fed mice. (E) Representative Oil- Red O staining of liver tissues. Portal triad (PT) and central vein (CV). Scale bars, 50 μm.
EtOH exposure increases the expression of alcohol dehydrogenase 1 (ADH1) in cultured primary PDGFRα+LepR+ BM-MSCs. (A) Feature plots for scRNA-seq of BM niche in control WT mice (GSE108892) (left), and representative H&E and CYP2E1 immunostaining images of the BM of WT mice fed either a Pair-fed or EtOH diet for 8 weeks (right). Yellow triangles indicate BM-MSCs. Scale bars, 100 μm. (B) Gating strategies of mouse PDGFRα+LepR+ BM-MSCs with representative plots. (C) Representative phase-contrast (left) and immunostaining (right) images of BM-MSCs cultured for 14 days (D14). Scale bars, 50 μm (left), 100 μm (right). (D) Representative immunostaining images of D14-cultured BM-MSCs after 100 mM EtOH for 48 hours. Scale bars, 50 μm. ADH1, alcohol dehydrogenase 1; CYP2E1, cytochrome P450 2E1; LepR, leptin receptor; PDGFRα, platelet-derived growth factor receptor alpha.
Alteration in mGluR expression and phenotypic characteristics of BM lymphocytes following chronic alcohol consumption. (A) qRT-PCR analysis for metabotropic glutamate receptors (mGluRs) in monocytes and lymphocytes including CD4 T, CD8 T, NK, and NKT cells isolated from WT BM fed either a Pair-fed or EtOH diet for 8 weeks (n=3/group). (B, C) Flow cytometric analysis of frequency changes in BM lymphocytes, with representative histograms and quantification of CXCR3 and CXCR4 expression, in WT mice fed a Pair-fed or EtOH diet for 8 weeks (n=5/group). (D) Isolated BM NK cells from WT mice were treated with mGluR5-specific agonist CHPG (10 μM) for 30 minutes and subjected to qRT-PCR analysis (n=3/group). (E) Expression of Ifng in BM NK cells after treatments with glutamate w/o mGluR5 antagonist (CTEP). (F) Serum IFN-γ levels were measured (n=5/group). Data are presented as mean±standard error of the mean. *P<0.05, **P<0.01, ***P<0.001. Not detected (n.d.).
EtOH exposure upregulates CX3CL1 expression in BM-MSCs and enhances the migration of BM monocytes toward BM-MSCs, whereas IFN-γ significantly inhibits this migration. (A) Flow cytometry analysis for the surface expression of CCR2 in hepatic macrophages and BM monocytes of WT mice fed a Pair-fed or EtOH diet for 8 weeks, with representative histograms (n=5/ group). (B) qRT-PCR analysis for Ccr2 expression in Ly6Clow BM monocytes treated with IFN-γ for 3 hours. (C) STAT1 chromatin immunoprecipitation sequencing (ChIP-seq) analysis of mouse BM-derived macrophages (GSE115433). TSS, transcription start site. (D) qRTPCR analysis for Cx3cl1 expression in BM-MSCs exposed to EtOH for 9 hours. (E, F) BM MSCs were isolated from WT mice and cultured for 14 days followed by vehicle (PBS) or ethanol (50 mM) for 3 hours. BM monocytes were sorted from eGFP mice (E) or WT or CX3CR1GFP/GFP mice (F) and treated with vehicle (PBS) or IFN-γ (1 ng/mL) for 3 hours. (E) Migration assay of IFN-γ-treated eGFP+ BM monocytes to EtOH-exposed BM-MSCs. Scale bars, 50 μm. (F) Schematic summary of experimental setting (top). The number of migrated monocytes was measured (bottom). Data are presented as mean±standard error of the mean. *P<0.05, **P<0.01, ***P<0.001.
Genetic ablation of xCT in LepR+ MSCs increases inflammatory gene expression in liver MNCs and reduces blood Ly6Clow monocytes upon chronic alcohol intake. Slc7a11f/f and Slc7a11LepR mice were fed EtOH diet for 8 weeks (n=6/group). (A) Body weight changes and mean dietary intake. (B) qRT-PCR analysis of isolated liver MNCs (n=3/group). (C) Flow cytometry analysis for CCR2 expression in F4/80+CD11b+ hepatic macrophages. Black dashed line indicates the values of isotype controls. (D) Flow cytometry analysis for F4/80+CD11b+ blood monocytes. Data are presented as mean±standard error of the mean. *P<0.05, **P<0.01.
NK cell-specific mGluR5 deficiency exacerbates alcohol-associated liver injury, but recombinant IL-1R2 treatment attenuates ALD. (A–E) Grm5f/f and Grm5NK mice were fed an EtOH diet for 8 weeks (n=6/group). (A) Body weight changes and mean dietary intake. (B) Flow cytometry analysis for CXCR3 expression in BM lymphocytes with representative histograms. (C) Inflammatory foci were counted in liver tissues after H&E staining. (D) qRT-PCR analysis of isolated liver MNCs (n=3/group). (E) The frequencies and IL-1R2 expression of Ly6Chigh and Ly6Clow hepatic macrophages were analyzed by flow cytometry analysis. (F, G) WT mice were fed a 5% EtOH diet for 8 days and then randomly divided into two groups. Each group was intraperitoneally injected either with recombinant IL-1R2 (rcIL-1R2) (0.1 mg/kg) or vehicle (Veh) for 3 consecutive days, immediately prior to oral gavage with 4 g/kg of 40% EtOH (n=6 per group). (F) Body weight changes and mean dietary intake. (G) Representative CYP2E1 immunofluorescence staining and H&E staining of liver tissues from Veh- or rcIL-1R2-treated mice, with quantification of inflammatory foci. Scale bars, 50 μm. Data are presented as mean±standard error of the mean. *P<0.05, **P<0.01, ***P<0.001.
The frequencies of neutrophils and monocytes in the peripheral blood of patients with ALD remain unchanged. Peripheral blood samples from healthy controls (HCs; n=13) or patients with alcohol-associated steatotic liver (ASL; n=19) or alcohol-associated liver cirrhosis (ALC; n=16) were collected and analyzed (Supplementary Table 1). (A) Gating strategies and flow cytometric analysis for blood CD14+CD16+ non-classical (red rectangular), CD14hiCD16+ intermediate (black rectangular), and CD14hiCD16- classical (green rectangular) monocytes as well as CD11b+CD15+ neutrophils. (B, C) Flow cytometric analysis for CX3CR1 (B) and CCR2 (C) expression of blood monocytes. Data are presented as mean±standard error of the mean. *P<0.05.
Clinical characteristics of healthy controls and patients with alcohol-associated liver diseases
The list of antibodies
Primer sequences for qPCR
